Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Cancer Microenvironment

Issue 2/2013

Immunological aspect of the tumor microenvironment

Content (7 Articles)

Review Article

The Immune Microenvironment of Human Tumors: General Significance and Clinical Impact

Wolf-Herman Fridman, Marie-Caroline Dieu-Nosjean, Franck Pagès, Isabelle Cremer, Diane Damotte, Catherine Sautès-Fridman, Jérôme Galon

Open Access Original Paper

Effector CD4 and CD8 T Cells and Their Role in the Tumor Microenvironment

Sine Hadrup, Marco Donia, Per thor Straten

Original Article

Shaping of NK Cell Responses by the Tumor Microenvironment

Ana Stojanovic, Margareta P. Correia, Adelheid Cerwenka

Original Papers

Tumor-Infiltrating Regulatory T Cells: Phenotype, Role, Mechanism of Expansion In Situ and Clinical Significance

C. Tanchot, M. Terme, H. Pere, T. Tran, N. Benhamouda, M. Strioga, C. Banissi, L. Galluzzi, G. Kroemer, E. Tartour

Original Paper

Immunosuppressive Mechanisms of Regulatory Dendritic Cells in Cancer

Galina V. Shurin, Yang Ma, Michael R. Shurin

Original Paper

Tumor Microenvironment and Myeloid-Derived Suppressor Cells

Viktor Umansky, Alexandra Sevko

Original Article

Monocytes and Macrophages in Cancer: Development and Functions

David M. Richards, Jan Hettinger, Markus Feuerer

Apr 13
Issue: 1/2013
Dec 13
Issue: 3/2013

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits